BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 241 filers reported holding BEAM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $98,460 | -73.0% | 4,094 | -64.1% | 0.00% | -75.0% |
| Q2 2023 | $364,609 | +210656.6% | 11,419 | +101.7% | 0.01% | +100.0% |
| Q1 2023 | $173 | +183.6% | 5,660 | +260.5% | 0.01% | +100.0% |
| Q4 2022 | $61 | -100.0% | 1,570 | -95.4% | 0.00% | -88.9% |
| Q3 2022 | $1,642,000 | +75.4% | 34,463 | +42.5% | 0.03% | +28.6% |
| Q2 2022 | $936,000 | -28.2% | 24,182 | +6.3% | 0.02% | +75.0% |
| Q1 2022 | $1,303,000 | +506.0% | 22,749 | +745.7% | 0.01% | +200.0% |
| Q4 2021 | $215,000 | -42.8% | 2,690 | -37.7% | 0.00% | -60.0% |
| Q3 2021 | $376,000 | +32.9% | 4,316 | +96.6% | 0.01% | +42.9% |
| Q2 2021 | $283,000 | -83.6% | 2,195 | -89.8% | 0.01% | -75.9% |
| Q1 2021 | $1,726,000 | +505.6% | 21,565 | +517.9% | 0.03% | +222.2% |
| Q4 2020 | $285,000 | -35.1% | 3,490 | -80.4% | 0.01% | +80.0% |
| Q3 2020 | $439,000 | +501.4% | 17,839 | +582.4% | 0.01% | +66.7% |
| Q2 2020 | $73,000 | – | 2,614 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |